Press release
Global Injectable Drug Delivery Market is Determined to Cross US$ 624.5 Billion By 2022
Florida, January 23, 2018: The Global Injectable Drug Delivery Market is expected to exceed more than US$ 624.5 Billion by 2022 at a CAGR of 11.5% in the given forecast period.Creating delivery devices for injectable drugs has been one of the Challenging task of today. As great number of innovation oriented advancements have occurred in the biologics market, which additionally increases the applicability of the injectable devices in the complex disease areas. The expansion in number of chronic illnesses like diabetes and cancer has increased the requirement for Injectable drugs delivery. Unlike other conventional methods of drug delivery, injectable allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With considerable development in mechanical headways, the devices being produced and marketed in order to take into account the particular needs of the patients.
You Can Find Full Report: https://www.marketresearchengine.com/injectable-drug-delivery-market
This report provides:
1) An overview of the global market for Global Injectable Drug Delivery Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Injectable Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Global Injectable Drug Delivery Market are as follows:
• Escalation in demand for self- injection devices
• Increase in number of chronic diseases
• Biosimilars
• New Product Launches and Technological Advancements
• Innovative technological progress
• Development of the biologics market
The restraining factors of Global Injectable Drug Delivery Market are as follows:
• Needle stick injuries and infections
• Product recalls
• Optional mode of drug delivery
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Request Sample Report here @: https://www.marketresearchengine.com/injectable-drug-delivery-market
Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Devices
7.2.1 Conventional Injection Devices
7.2.1.1 By Material
7.2.1.1.1 Glass
7.2.1.1.2 Plastic
7.2.1.2 By Product
7.2.1.2.1 Fillable Syringes
7.2.1.2.2 Prefilled Syringes
7.2.1.3 By Usability
7.2.1.3.1 Reusable Injection Devices
7.2.1.3.2 Disposable Injection Devices
7.2.2 Self-Injection Devices
7.2.2.1 Needle-Free Injectors
7.2.2.1.1 By Product
7.2.2.1.1.1 Fillable Needle-Free Injectors
7.2.2.1.1.2 Prefilled Needle-Free Injectors
7.2.2.1.2 By Technology
7.2.2.1.2.1 Jet-Based Needle-Free Injectors
7.2.2.1.2.2 Spring-Based Needle-Free Injectors
7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
7.2.2.1.3 By Usability
7.2.2.1.3.1 Reusable Needle-Free Injectors
7.2.2.1.3.2 Disposable Needle-Free Injectors
7.2.2.2 Autoinjectors
7.2.2.2.1 By Product
7.2.2.2.1.1 Fillable Autoinjectors
7.2.2.2.1.2 Prefilled Autoinjectors
7.2.2.2.2 By Technology
7.2.2.2.2.1 Automated Autoinjectors
7.2.2.2.2.2 Manual Autoinjectors
7.2.2.2.3 By Design
7.2.2.2.3.1 Standardized Autoinjectors
7.2.2.2.3.2 Customized Autoinjectors
7.2.2.2.4 By Usability
7.2.2.2.4.1 Reusable Autoinjectors
7.2.2.2.4.2 Disposable Autoinjectors
7.2.2.3 Pen Injectors
7.2.2.3.1 By Product
7.2.2.3.1.1 Single-Chambered Pen Injectors
7.2.2.3.1.2 Dual-Chambered Pen Injectors
7.2.2.3.2 By Design
7.2.2.3.2.1 Standard Pen Injectors
7.2.2.3.2.2 Customized Pen Injectors
7.2.2.3.3 By Usability
7.2.2.3.3.1 Reusable Pen Injectors
7.2.2.3.3.2 Disposable Pen Injectors
7.2.2.4 Wearable Injectors
7.2.2.5 Other Devices
7.3 Formulations
7.3.1 Conventional Drug Delivery Formulations
7.3.1.1 Solutions
7.3.1.2 Reconstituted/Lyophilized Formulations
7.3.1.3 Suspensions
7.3.1.4 Emulsions
7.3.2 Novel Drug Delivery Formulations
7.3.2.1 Colloidal Dispersions
7.3.2.1.1 Niosomes
7.3.2.1.2 Liposomes
7.3.2.1.3 Polymeric/Mixed Micelles
7.3.2.1.4 Nanoparticles
7.3.2.1.4.1 Solid-Lipid Nanoparticles
7.3.2.1.4.2 Nanosuspensions
7.3.2.1.4.3 Nanoemulsions
7.3.2.2 Microparticles
7.3.2.2.1 Microspheres
7.3.2.2.2 Microcapsules
7.3.3 Long-Acting Injection Formulations
8 Injectable Drug Delivery Market, By Formulation Packaging
9 Injectable Drug Delivery Market, By Therapeutic Application
10 Injectable Drug Delivery Market, By Usage Pattern
11 Injectable Drug Delivery Market, By Site of Administration
12 Injectable Drug Delivery Market, By Distribution Channel
13 Injectable Drug Delivery Market, By Facility of Use
14 Injectable Drug Delivery Market, By Region
15 Competitive Landscape
16 Company Profiles
16.1 Introduction
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Gerresheimer AG
16.5 Pfizer, Inc.
16.6 Schott AG
16.7 ELI Lilly and Company
16.8 Sandoz (A Division of Novartis AG)
16.9 Terumo Corporation
16.10 Teva Pharmaceutical Industries Ltd.
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Injectable Drug Delivery Market is Determined to Cross US$ 624.5 Billion By 2022 here
News-ID: 913753 • Views: …
More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018:
Weight Management Market 2018
The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…

Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018:
Home Healthcare Market 2018
The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…

Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018:
Healthcare 3D Printing Market 2018
The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS…

Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018:
Tumor Ablation Market 2018
The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…